Proton-Pump Inhibitors and Hypomagnesaemia in Kidney Transplant Recipients

Proton-pump inhibitors (PPIs) are commonly used after kidney transplantation and there is rarely an incentive to discontinue treatment. In the general population, PPI use has been associated with hypomagnesaemia. We aimed to investigate whether PPI use is associated with plasma magnesium, 24-h urina...

Descripción completa

Detalles Bibliográficos
Autores principales: Douwes, Rianne M., Gomes-Neto, António W., Schutten, Joëlle C., van den Berg, Else, de Borst, Martin H., Berger, Stefan P., Touw, Daan J., Hak, Eelko, Blokzijl, Hans, Navis, Gerjan, Bakker, Stephan J. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947083/
https://www.ncbi.nlm.nih.gov/pubmed/31817776
http://dx.doi.org/10.3390/jcm8122162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947083/
https://www.ncbi.nlm.nih.gov/pubmed/31817776
http://dx.doi.org/10.3390/jcm8122162

Ejemplares similares